940 related articles for article (PubMed ID: 19135136)
21. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
22. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
23. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.
Ho DT; Bardwell AJ; Grewal S; Iverson C; Bardwell L
J Biol Chem; 2006 May; 281(19):13169-13179. PubMed ID: 16533805
[TBL] [Abstract][Full Text] [Related]
24. Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia.
Ginet V; Puyal J; Magnin G; Clarke PG; Truttmann AC
J Neurochem; 2009 Feb; 108(3):552-62. PubMed ID: 19046406
[TBL] [Abstract][Full Text] [Related]
25. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses.
Moriguchi T; Toyoshima F; Masuyama N; Hanafusa H; Gotoh Y; Nishida E
EMBO J; 1997 Dec; 16(23):7045-53. PubMed ID: 9384583
[TBL] [Abstract][Full Text] [Related]
26. Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells.
Hirata Y; Furuta K; Miyazaki S; Suzuki M; Kiuchi K
Brain Res; 2004 Sep; 1021(2):241-7. PubMed ID: 15342272
[TBL] [Abstract][Full Text] [Related]
27. Identification of ASK1, MKK4, JNK, c-Jun, and caspase-3 as a signaling cascade involved in cadmium-induced neuronal cell apoptosis.
Kim SD; Moon CK; Eun SY; Ryu PD; Jo SA
Biochem Biophys Res Commun; 2005 Mar; 328(1):326-34. PubMed ID: 15670787
[TBL] [Abstract][Full Text] [Related]
28. Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides.
Kelemen BR; Hsiao K; Goueli SA
J Biol Chem; 2002 Mar; 277(10):8741-8. PubMed ID: 11756441
[TBL] [Abstract][Full Text] [Related]
29. Requirements for PKC-augmented JNK activation by MKK4/7.
Lopez-Bergami P; Ronai Z
Int J Biochem Cell Biol; 2008; 40(5):1055-64. PubMed ID: 18182317
[TBL] [Abstract][Full Text] [Related]
30. Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases.
Caughlan A; Newhouse K; Namgung U; Xia Z
Toxicol Sci; 2004 Mar; 78(1):125-34. PubMed ID: 14691213
[TBL] [Abstract][Full Text] [Related]
31. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
32. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons.
Coffey ET; Hongisto V; Dickens M; Davis RJ; Courtney MJ
J Neurosci; 2000 Oct; 20(20):7602-13. PubMed ID: 11027220
[TBL] [Abstract][Full Text] [Related]
33. c-Jun N-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus.
Spigolon G; Veronesi C; Bonny C; Vercelli A
Eur J Neurosci; 2010 Apr; 31(7):1261-72. PubMed ID: 20345908
[TBL] [Abstract][Full Text] [Related]
34. Multiple pathways of apolipoprotein E signaling in primary neurons.
Hoe HS; Harris DC; Rebeck GW
J Neurochem; 2005 Apr; 93(1):145-55. PubMed ID: 15773914
[TBL] [Abstract][Full Text] [Related]
35. SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes.
Henklova P; Vrzal R; Papouskova B; Bednar P; Jancova P; Anzenbacherova E; Ulrichova J; Maurel P; Pavek P; Dvorak Z
Eur J Pharmacol; 2008 Sep; 593(1-3):16-23. PubMed ID: 18655782
[TBL] [Abstract][Full Text] [Related]
36. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
[TBL] [Abstract][Full Text] [Related]
37. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes.
Nishitani K; Ito H; Hiramitsu T; Tsutsumi R; Tanida S; Kitaori T; Yoshitomi H; Kobayashi M; Nakamura T
J Cell Biochem; 2010 Feb; 109(2):425-33. PubMed ID: 19998410
[TBL] [Abstract][Full Text] [Related]
38. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
39. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
40. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
